-
EP1729766
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1729766
| EP1729766 - PHARMACEUTICAL FORMULATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.01.2014 Database last updated on 24.08.2024 | Most recent event Tooltip | 03.01.2014 | Application deemed to be withdrawn | published on 05.02.2014 [2014/06] | Applicant(s) | For all designated states LEK Pharmaceuticals d.d. Verovskova 57 1526 Ljubljana / SI | [2010/10] |
| Former [2006/50] | For all designated states LEK Pharmaceuticals d.d. Verovskova 57 1526 Ljubljana / SI | Inventor(s) | 01 /
SVETE, Peter Gradisnikova 14 1353 Borovnica / SI | 02 /
GRAHEK, Rok Zoisova 17 4000 Kranj / SI | 03 /
HUMAR, Vlasta Godic 63 1242 Stahovica / SI | 04 /
HUSU-KOVACEVIC, Breda Na peci 27 1000 Ljubljana / SI | 05 /
JERALA-STRUKELJ, Zdenka Podreca 107 4211 Mavcice / SI | [2006/50] | Representative(s) | Prüfer & Partner mbB Patentanwälte Rechtsanwälte Sohnckestrasse 12 81479 München / DE | [N/P] |
| Former [2012/14] | Prüfer & Partner GbR European Patent Attorneys Sohnckestrasse 12 81479 München / DE | ||
| Former [2010/10] | (deleted) | ||
| Former [2008/25] | Kröger, Bernd, et al Sandoz International GmbH Global Patents Department Industriestrasse 25 83607 Holzkirchen / DE | ||
| Former [2006/50] | Skulj, Primoz, et al Novartis AG Corporate Intellectual Property 4002 Basel / CH | Application number, filing date | 05707662.2 | 28.02.2005 | [2006/50] | WO2005EP02108 | Priority number, date | SI20040000067 | 01.03.2004 Original published format: SI 200400067 | [2006/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005084670 | Date: | 15.09.2005 | Language: | EN | [2005/37] | Type: | A1 Application with search report | No.: | EP1729766 | Date: | 13.12.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.09.2005 takes the place of the publication of the European patent application. | [2006/50] | Search report(s) | International search report - published on: | EP | 15.09.2005 | Classification | IPC: | A61K31/4184, A61K31/695, A61K9/28, C07D403/10 | [2006/50] | CPC: |
A61K31/4174 (EP);
A61K9/28 (US);
A61K31/4184 (US);
A61K31/695 (US);
A61K9/2009 (EP);
A61K9/282 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/50] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | PHARMAZEUTISCHE FORMULIERUNG | [2006/50] | English: | PHARMACEUTICAL FORMULATION | [2006/50] | French: | FORMULATION PHARMACEUTIQUE | [2006/50] | Entry into regional phase | 02.10.2006 | National basic fee paid | 02.10.2006 | Designation fee(s) paid | 02.10.2006 | Examination fee paid | Examination procedure | 15.12.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 02.10.2006 | Examination requested [2006/50] | 15.11.2007 | Despatch of a communication from the examining division (Time limit: M04) | 22.11.2007 | Observations by third parties | 27.06.2008 | Reply to a communication from the examining division | 03.09.2013 | Application deemed to be withdrawn, date of legal effect [2014/06] | 27.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.11.2007 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 27.06.2008 | Request for further processing filed | 27.06.2008 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 28.02.2007 | Renewal fee patent year 03 | 13.02.2008 | Renewal fee patent year 04 | 13.02.2009 | Renewal fee patent year 05 | 16.02.2010 | Renewal fee patent year 06 | 15.02.2011 | Renewal fee patent year 07 | 15.02.2012 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 28.02.2013 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US5140037 (CHIU ANDREW T [US], et al) [A] 1-17* the whole document *; | [X]US5225202 (HODGES GARRY R [GB], et al) [X] 1,11 * column 3 - column 4; examples 1,2; claims 15,18,20,23,29,30 *; | [X]WO9517396 (MERCK & CO INC [US], et al) [X] 1-17 * page 1 * * page 38 - page 42; claim 1 *; | [X]US5962500 (EIDE IVAR K [US], et al) [X] 1,11-13 * column 29 *; | [A]WO0193859 (LEK TOVARNA FARMACEVTSKIH [SI], et al) [A] 1-17 * page 3 - page 6 * * page 16 - page 18 *; | [A]WO02094816 (AUROBINDO PHARMA LTD [IN]) [A] 1-4,11-13 * the whole document *; | [XD]WO03048135 (TEVA PHARMA [IL], et al) [XD] 1-17 * paragraphs [0007] , [0077] - [0087] - [0114] - [0128] * | other | EP0546358 | - WATANABE T; ET AL, "Stability of amorphous indomethacin compounded with silica", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (2001), vol. 226, pages 81 - 91, XP002310637 DOI: http://dx.doi.org/10.1016/S0378-5173(01)00776-1 | - BAUER K.H. ET AL., Pharmazeutische Technologie, 4e Auflage, GEORG THIEME VERLAG, (1993), XP003017486 |